指南与共识细菌感染、耐药与抗菌药物

中空纤维感染模型(HFIM)在抗菌药物研发中的应用:系统综述与报告建议

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting.
指南 / 共识 · J Antimicrob Chemother · 2021-01-01

该系统综述检索6个数据库至2020年1月,纳入129项使用体外中空纤维感染模型(HFIM)进行微生物培养的研究,分析其微生物学和技术参数的报告质量。结论认为多数文献数据不足,影响HFIM实验的可重复性,亟需实验室标准化和报告改进。

要点

  • 36.4%的研究未报告复制药代动力学特征所需的最低参数。
  • 41.1%的文献未报告HFIM所用培养基,82.9%未做技术重复,75.2%未做生物学重复。
  • 现有HFIM文献报告不足,影响结果评估和实验可重复性。

核心结论

  • 大多数HFIM相关文献提供的数据不足以评估结果,损害了实验的可重复性。
  • 有必要建立实验室标准化并改进HFIM实验的报告。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE、PubMed、BIOSIS、SCOPUS和Cochrane六个数据库至2020年1月。
  • 纳入129项符合标准的研究,由两名评价员独立评估并提取数据。

主要发现

  • 107/129(82.9%)的文献未进行技术重复,97/129(75.2%)未进行生物学重复。

临床怎么用

  • 开展HFIM实验时应报告复制药代动力学特征所需的最低参数。
  • 应明确记录所用培养基,并进行技术重复和生物学重复以提高可重复性。
  • 建议遵循标准化的报告规范以提升研究质量。

局限性

  • 检索截止于2020年1月,未纳入此后发表的文献。
  • 仅评估报告质量,未对实验数据本身进行合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This systematic review focuses on the use of the in vitro hollow fibre infection model (HFIM) for microbial culture. We summarize the direction of the field to date and propose best-practice principles for reporting of the applications. METHODS: Searches in six databases (MEDLINE®, EMBASE®, PubMed®, BIOSIS®, SCOPUS® and Cochrane®) up to January 2020 identified 129 studies meeting our inclusion criteria. Two reviewers independently assessed and extracted data from each publication. The quality of reporting of microbiological and technical parameters was analysed. RESULTS: Forty-seven out of 129 (36.4%) studies did not report the minimum pharmacokinetic parameters required in order to replicate the pharmacokinetic profile of HFIM experiments. Fifty-three out of 129 (41.1%) publications did not report the medium used in the HFIM. The overwhelming majority of publications did not perform any technical repeats [107/129 (82.9%)] or biological repeats [97/129 (75.2%)]. CONCLUSIONS: This review demonstrates that most publications provide insufficient data to allow for results to be evaluated, thus impairing the reproducibility of HFIM experiments. Therefore, there is a clear need for the development of laboratory standardization and improved reporting of HFIM experiments.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Sadouki Z, McHugh TD, Aarnoutse R, et al. Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. J Antimicrob Chemother. 2021. PMID: 34179966. doi:10.1093/jac/dkab160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。